B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sufentanil

298 PubMed studies analyzed ยท 112 RCTs ยท Evidence Score: 57

Research Domains

Sufentanil has been studied across 17 research domains including ๐Ÿ’Š Pain, ๐Ÿ˜ด Sleep, โค๏ธ Cardiovascular, ๐Ÿง  Focus & Attention, ๐Ÿ”ฌ Oncology. The primary research focus is ๐Ÿ’Š Pain with 56% of studies addressing this area.

Loading evidence profile...

This evidence profile for Sufentanil is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.